- Research works
- 43 ▲ 11% vs 2013–17
- Citations
- 1.8k 42.3 per fractional work
- Top-10% rate
- 55.0% record average 16.5%
- Open access
- 37% world 28%
Not ranked overall: BioPAL (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at BioPAL (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Monoclonal Antibodies, Glycosylation, Therapeutic Antibodies, Cancer, Antibody Engineering, Fc Receptors, Inflammation and Cancer Therapy.
- Cell Death
- Mass Spectrometry
- Inflammatory Bowel Disease
- Biomedical Applications
- TGF-ß
- Lymphoma
- Epidemiology
- Angiogenesis
- Gene Expression
- Chronic Kidney Disease
- Nanoparticles
- Chromatography
- Mucins
- Glycans
- Recombinant Proteins
- Therapeutics
- Cancer Therapy
- Antibody Engineering
- Cancer
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Inflammation
- Fc Receptors
- Biopharmaceuticals
- Immunogenicity
- Tumor Microenvironment
- Immune System
- Protein Aggregation
- Immunotherapy
- Stability
- Biomarkers
- RNA Interference
- Autoantibodies
- Immune Response
- Quality of Life
- Autoimmunity
- Hemodialysis
- Leukemia
- Oxidative Stress
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycosylation6▲ 57×3 topics
- Monoclonal Antibodies6▲ 89×3 topics
- Therapeutic Antibodies5▲ 93×2 topics
- Cancer4▲ 7.4×10 topics
- Inflammation4▲ 4.1×15 topics
- Antibody Engineering4▲ 85×1 topic
- Fc Receptors4▲ 85×1 topic
- Cancer Therapy2▲ 8.5×7 topics
- Biopharmaceuticals2▲ 75×3 topics
- Therapeutics2▲ 33×2 topics
- Immunogenicity2▲ 84×2 topics
- Recombinant Proteins2▲ 81×2 topics
- Tumor Microenvironment2▲ 13×4 topics
- Glycans2▲ 48×1 topic
- Immune System2▲ 12×2 topics
- Mucins2▲ 48×1 topic
- Protein Aggregation2▲ 47×2 topics
- Chromatography2▲ 122×1 topic
- Immunotherapy2▲ 5.2×4 topics
- Nanoparticles2▲ 2.6×5 topics
- Stability2▲ 18×1 topic
- Chronic Kidney Disease1▲ 13×3 topics
- Biomarkers1▲ 4.8×4 topics
- Gene Expression1▲ 5.0×5 topics
- RNA Interference1▲ 27×2 topics
- Angiogenesis1▲ 7.0×5 topics
- Autoantibodies1▲ 12×3 topics
- Epidemiology1▼ 0.70×6 topics
- Immune Response1▲ 4.4×3 topics
- Lymphoma1▲ 19×3 topics
- Quality of Life1▲ 2.0×3 topics
- TGF-ß1▲ 16×2 topics
- Autoimmunity1▲ 13×2 topics
- Biomedical Applications1▲ 2.4×3 topics
- Hemodialysis1▲ 34×2 topics
- Inflammatory Bowel Disease1▲ 24×3 topics
- Leukemia1▲ 37×2 topics
- Mass Spectrometry1▲ 12×3 topics
- Oxidative Stress1▲ 1.42×7 topics
- Cell Death1▲ 12×3 topics
Which research topics does BioPAL (United States) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers and HER2/EGFR in Cancer Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 2 CAR-T cell therapy research Oncology 1 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 4 HER2/EGFR in Cancer Research Oncology 0 works
- 5 Biosimilars and Bioanalytical Methods Immunology 0 works
- 6 Apelin-related biomedical research Pharmacology 0 works
- 7 Cancer Research and Treatment Oncology 0 works
- 8 Renin-Angiotensin System Studies Cardiology and Cardiovascular Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has BioPAL (United States)'s research output changed?
Output in 2018–2022 was 11% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Worcester
- University of Massachusetts Chan Medical School
- Worcester Polytechnic Institute
- Clark University
- College of the Holy Cross
- UMass Memorial Health Care
- Worcester State University
- UMass Memorial Medical Center
- Eunice Kennedy Shriver Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.